Article Information
- Received December 13, 2001
- Revision received February 25, 2002
- Accepted March 8, 2002
- First published July 1, 2002.
- Version of record published July 1, 2002.
Author Information
Author contributions
Disclosures
- Received December 13, 2001.
- Revision received February 25, 2002.
- Accepted March 8, 2002.
This work was supported by National Institutes of Health Grant GM63496 and a German National Merit Scholarship Foundation scholarship (F.W.J.). Antibodies for the ryanodine receptor were kindly provided by Dr. Vincenzo Sorrentino. InsP3R type II antibodies were a kind gift from Dr. Richard Wojcikiewicz. We thank the Biotechnology and Biological Sciences Research Council (United Kingdom) for financial support and the Engineering and Physical Sciences Research Council (United Kingdom) for provision of the Swansea Mass Spectrometry Service. We thank Drs. Martin Bootman and Peter Lipp for helpful discussions and access to InsP3-BM ester. Drs. E. Thrower, A. Sardini, and M. Nathanson made helpful comments on this manuscript, and B. DeGray provided excellent technical support.
Correspondence should be addressed to Barbara E. Ehrlich, Department of Pharmacology, Yale University, 333 Cedar Street, New Haven, CT 06520-8066. E-mail: barbara.ehrlich{at}yale.edu.
M. Zochowski's present address: Department of Physics, University of Michigan, Ann Arbor, MI 48109.
P. Koulen's present address: Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699.
Online Impact